ACL 4.00% $2.40 australian clinical labs limited

Ann: Media Release - 1H22 Financial Results, page-3

  1. 40 Posts.
    lightbulb Created with Sketch. 11
    As a recent investor to this share, im very happy with the maiden half year results, company seems to have a strong managment team with a clear plan they are executing on.
    The maiden Div was much higher than expected so very much looking forward to continue to reinvest in this company.
    Minus the one Downramper that has been posting on ACL Im very happy where they are heading.
 
watchlist Created with Sketch. Add ACL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.